BNP Paribas Financial Markets
INMB icon

BNP Paribas Financial Markets’s INmune Bio INMB Stock Holding History

BNP Paribas Financial Markets’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.11K Buy
7,178
+577
+9% +$822 ﹤0.01% 5252
2025
Q4 		$10.3K Buy
6,601
+2,684
+69% +$4.79K ﹤0.01% 5152
2025
Q3 		$8.11K Buy
3,917
+2,359
+151% +$5.4K ﹤0.01% 5042
2025
Q2 		$3.6K Buy
1,558
+828
+113% +$6.08K ﹤0.01% 4991
2025
Q1 		$5.7K Sell
730
-24,783
-97% -$197K ﹤0.01% 4827
2024
Q4 		$119K Buy
25,513
+22,678
+800% +$118K ﹤0.01% 4103
2024
Q3 		$15.3K Buy
2,835
+1,956
+223% +$13.9K ﹤0.01% 3771
2024
Q2 		$7.75K Buy
+879
New +$8.66K ﹤0.01% 3747
2022
Q4 		– Sell
-371
Closed -$2.3K – 4312
2022
Q3 		$2.3K Buy
+371
New +$3.26K ﹤0.01% 4332

Other funds holding INMB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BNP Paribas Financial Markets's INMB Position: Q1 2026 in Review

BNP Paribas Financial Markets increased its INmune Bio (INMB) stake by 8.7% in Q1 2026, buying an estimated $822 and bringing the position to 7,178 shares worth $8.11K. The position accounts for ﹤0.01% of the portfolio, ranked #5252.

BNP Paribas Financial Markets first reported a position in INMB in Q3 2022 and has held it in 9 quarters since. The position peaked at $119K in Q4 2024. 82 funds tracked by Wall St. Rank hold INMB as of Q1 2026.

  • BNP Paribas Financial Markets held 7,178 shares of INmune Bio worth $8.11K as of Q1 2026.
  • BNP Paribas Financial Markets bought 577 INmune Bio shares in Q1 2026, an estimated $822.
  • INmune Bio made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #5252 holding.
  • BNP Paribas Financial Markets first reported a position in INmune Bio in Q3 2022 and has held it in 9 quarters since.
  • BNP Paribas Financial Markets's INmune Bio position peaked at $119K in Q4 2024.
  • 82 funds tracked by Wall St. Rank held INmune Bio as of Q1 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.